Latest S-1 registration statements

BitGo Holdings, a leading digital asset infrastructure provider, filed an S-1/A registration statement detailing its robust growth, diversified platform, and upcoming initial public offering.

Cycurion, Inc. filed an S-1/A registration statement for a primary offering of up to 7,000,000 shares under an Equity Purchase Agreement and a secondary offering of various securities, while reporting significant net losses and a going concern doubt.

Kestra Medical Technologies, Ltd. filed an S-1MEF to register an additional 575,000 common shares, including 75,000 for underwriters' option, for its public offering.

Guident Corp. files for an initial public offering of 1,704,545 shares of common stock on Nasdaq, aiming to raise approximately $12.86 million to fund its autonomous vehicle and robot teleoperation services.

JOSS Realty REIT, Inc. files for an initial public offering of 3 million common shares, targeting urban multi-tenant office properties and REIT qualification by year-end 2025, despite recurring net losses and going concern doubt.

SilverBox Corp V filed an S-1MEF to register an additional 4.6 million units, including an over-allotment option, for its public offering.

Cortigent, a pioneer in neurostimulation, is launching an IPO to fund the development of its Orion artificial vision system and Stroke Recovery System, targeting significant unmet medical needs despite a history of operating losses.

Reeds Inc. is offering 1.58 million shares of common stock and accompanying warrants to fund growth initiatives and working capital, following a 1-for-6 reverse stock split.

Actelis Networks filed an S-1 registration statement for the resale of 680,422 common shares by selling stockholders, following multiple recent capital raises and ongoing Nasdaq compliance efforts.

Upexi, Inc. has significantly shifted its treasury strategy to focus on Solana (SOL) holdings and staking, while registering over 6.5 million shares for resale by a selling stockholder.

Canary American-Made Crypto ETF files an amendment to its S-1 registration statement, outlining its strategy to invest in U.S.-centric crypto assets and generate staking rewards.

SPACSphere Acquisition Corp. filed an amended S-1 registration statement detailing its $150 million initial public offering, comprising units of Class A ordinary shares, redeemable warrants, and rights, and outlining its blank check company structure and acquisition strategy.

Jet.AI Inc. is offering 2,000,000 shares of Common Stock and Pre-Funded Warrants to raise capital for its strategic pivot into AI data center operations, while divesting its fractional and jet card aviation business.

Buda Juice, a pioneer in the UltraFreshTM juice category, files for an IPO to raise up to $20 million, targeting NYSE listing and funding national expansion and a CEO stock redemption.

Envoy Medical, a hearing health company, filed an S-1/A registration statement to allow selling stockholders to resell up to 15.1 million shares, while detailing ongoing clinical trials for its Acclaim CI, significant financial losses, and Nasdaq compliance challenges.

Thunderstone Acquisition Corp, a Cayman Islands blank check company, filed an S-1/A for an initial public offering of 5,000,000 units at $10.00 each, aiming to raise $50 million for a business combination.

Kestra Medical Technologies is launching a public offering of 5.5 million common shares to fund growth, reporting significant revenue increases and validating its ASSURE WCD's clinical benefits.

Invesco Galaxy Solana ETF files an amended registration statement for a spot Solana exchange-traded fund, aiming to track SOL's price and generate staking rewards.

Blaize Holdings, an AI edge computing solutions provider, reported significant operating losses and negative cash flows, raising substantial doubt about its ability to continue as a going concern, despite securing $80 million in recent financing.

Flora Growth Corp., soon to be ZeroStack, is undergoing a major strategic shift towards AI infrastructure and digital assets, backed by significant private placements and a new $50 million equity line of credit.

Abpro Holdings, a preclinical biotechnology company, filed an S-1/A to register shares for resale under a $50 million equity purchase agreement, while facing substantial doubt about its ability to continue as a going concern and multiple Nasdaq delisting notices.

AsiaFIN Holdings Corp. filed an amended S-1 registration statement for a public offering of 2 million common shares, targeting a NYSE American listing and outlining its FinTech, RegTech, and RPA expansion plans.

XCF Global, Inc. reports substantial doubt about its going concern ability, facing significant debt defaults and production issues at its key Reno SAF facility, alongside plans for future expansion and capital raises.

XCF Global, Inc. filed an S-1/A registration statement for the resale of up to $50 million in Class A common stock via an equity line of credit, while grappling with significant liquidity issues and production delays at its Reno SAF facility.

Jupiter Neurosciences, a clinical-stage pharmaceutical company, has entered a $20 million standby equity purchase agreement with Yorkville to fund its Parkinson's trial and Nugevia brand launch, despite significant and increasing net losses and a going concern warning.

Pasithea Therapeutics Corp. announced a public offering of up to $60 million in common stock and pre-funded warrants to fund its clinical-stage biotechnology programs, despite ongoing operating losses and Nasdaq compliance challenges.

Anteris Technologies Global Corp. filed an S-1 registration statement for the resale of up to 9.1 million common shares by selling stockholders, following a recent private placement and warrant issuance.

Genprex, a clinical-stage gene therapy company, filed an S-1/A to register 1.28 million shares for resale by selling stockholders, while detailing progress in its oncology and diabetes programs and recent financing activities.

Cycurion, Inc. reports continued operating losses and a significant accumulated deficit, raising substantial doubt about its ability to continue as a going concern, despite recent capital raising efforts and Nasdaq compliance.

Angel Studios, Inc. filed a Pre-Effective Amendment No. 2 to its Form S-3 registration statement to register for resale up to 10,042,523 shares of common stock by selling securityholders.